Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers.

Vocka M, Zimovjanova M, Bielcikova Z, Tesarova P, Petruzelka L, Mateju M, Krizova L, Kotlas J, Soukupova J, Janatova M, Zemankova P, Kleiblova P, Novotny J, Konopasek B, Chodacka M, Brychta M, Sochor M, Smejkalova-Musilova D, Cmejlova V, Kozevnikovova R, Miskarova L, Argalacsova S, Stolarova L, Lhotova K, Borecka M, Kleibl Z.

Cancers (Basel). 2019 May 28;11(6). pii: E738. doi: 10.3390/cancers11060738.

2.

Impact of ABCB1 and CYP2D6 polymorphisms on tamoxifen treatment outcomes and adverse events in breast cancer patients.

Argalacsova S, Slanar O, Bakhouche H, Pertuzelka L.

J BUON. 2017 Sep-Oct;22(5):1217-1226.

3.

Results of combined radiotherapy and hormonal treatment of prostate cancer patients with initial PSA value >40 ng/ml.

Kubeš J, Jakub C, Vladimir V, Jan D, Sona A, Matej N, Jan B.

Rep Pract Oncol Radiother. 2012 Feb 9;17(2):79-84. doi: 10.1016/j.rpor.2012.01.006. eCollection 2012.

Supplemental Content

Loading ...
Support Center